Rockville, Md. (EGMN) -- A Food and Drug Administration advisory panel was split on whether the efficacy and safety data on doripenem, an injectable, broad-spectrum antibiotic, were adequate to support its approval for treating nosocomial pneumonia, including ventilator-associated pneumonia.